An Intelligent Decision-Making Support System for the Detection and Staging of Prostate Cancer in Developing Countries

Most developing countries face huge challenges in the medical field; scarce medical resources and inadequate medical personnel will affect the development and stability of the society. Therefore, for most developing countries, the development of intelligent medical systems can greatly alleviate the social contradictions arising from this problem. In this study, a new data decisionmaking intelligent system for prostate cancer based on perceptron neural network is proposed, which mainly makes decisions by associating some relevant disease indicators and combining them with medical images. Through data collection, analysis and integration of medical data, as well as the disease detection and decision-making process, patients are given an auxiliary diagnosis and treatment, so as to solve the problems and social contradictions faced by most developing countries. Through the study of hospitalization information of more than 8,000 prostate patients in three hospitals, about 2,156,528 data items were collected and compiled for experiment purposes. Experimental data shows that when the patient base increases from 200 to 8,000, the accuracy of the machine-assisted diagnostic system will increase from 61% to 87%, and the doctor’s diagnosis rate will be reduced to 81%. From the study, it is concluded that when the patient base reaches a certain number, the diagnostic accuracy of the machine-assisted diagnosis system will exceed the doctor’s expertise. Therefore, intelligent systems can help doctors and medical experts treat patients more effectively.

[1]  Luiz Eduardo Soares de Oliveira,et al.  Breast cancer histopathological image classification using Convolutional Neural Networks , 2016, 2016 International Joint Conference on Neural Networks (IJCNN).

[2]  N. Hirmas,et al.  [68Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer , 2018, Molecular Imaging and Biology.

[3]  Michael Berks,et al.  Prediction of reader estimates of mammographic density using convolutional neural networks , 2019, Journal of medical imaging.

[4]  F. Bray,et al.  National economic and development indicators and international variation in prostate cancer incidence and mortality: an ecological analysis , 2017, World Journal of Urology.

[5]  S. Edge,et al.  Breast Cancer—Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual , 2017, CA: a cancer journal for clinicians.

[6]  Zhigang Chen,et al.  Decision based on big data research for non-small cell lung cancer in medical artificial system in developing country , 2018, Comput. Methods Programs Biomed..

[7]  J. Ferlay,et al.  Global cancer incidence in older adults, 2012 and 2035: A population‐based study , 2018, International journal of cancer.

[8]  Jia Wu,et al.  Diagnosis and Data Probability Decision Based on Non-Small Cell Lung Cancer in Medical System , 2019, IEEE Access.

[9]  S. Geeitha,et al.  Incorporating EBO-HSIC with SVM for Gene Selection Associated with Cervical Cancer Classification , 2018, Journal of Medical Systems.

[10]  E. Schaeffer,et al.  Re: Active surveillance for prostate cancer compared with immediate treatment: an economic analysis. , 2013, The Journal of urology.

[11]  A. Jemal,et al.  Annual Report to the Nation on the status of cancer, 1975‐2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer , 2014, Cancer.

[12]  M. Bock,et al.  Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology , 2017, Theranostics.

[13]  E. Uzunhisarcıklı,et al.  A novel classifier model for mass classification using BI-RADS category in ultrasound images based on Type-2 fuzzy inference system , 2018, Sādhanā.

[14]  Alan D. Lopez,et al.  Counting the dead and what they died from: an assessment of the global status of cause of death data. , 2005, Bulletin of the World Health Organization.

[15]  T. Coroller,et al.  Deep Learning Predicts Lung Cancer Treatment Response from Serial Medical Imaging , 2019, Clinical Cancer Research.

[16]  Murray H. Loew,et al.  Breast cancer detection using synthetic mammograms from generative adversarial networks in convolutional neural networks , 2018, Other Conferences.

[17]  C. Liang,et al.  The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer , 2019, Cancer medicine.

[18]  A. Kural,et al.  The accuracy of 68Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[19]  Asad Malik,et al.  Feature Selection Based on L1-Norm Support Vector Machine and Effective Recognition System for Parkinson’s Disease Using Voice Recordings , 2019, IEEE Access.

[20]  C. Pui,et al.  Saving the children--improving childhood cancer treatment in developing countries. , 2005, The New England journal of medicine.

[21]  Jalaluddin Khan,et al.  Intelligent Machine Learning Approach for Effective Recognition of Diabetes in E-Healthcare Using Clinical Data , 2020, Sensors.

[22]  M. Schonberg,et al.  Cancer Screening in the Elderly: A Review of Breast, Colorectal, Lung, and Prostate Cancer Screening , 2017, Cancer journal.

[23]  A. Bordoni,et al.  Trends in prostate cancer incidence between 1996 and 2013 in two Swiss regions by age, grade, and T-stage , 2018, Cancer Causes & Control.

[24]  O. Kim,et al.  miRNA polymorphisms (miR‑146a, miR‑149, miR‑196a2 and miR‑499) are associated with the risk of coronary artery disease. , 2016, Molecular medicine reports.

[25]  Tapabrata Maiti,et al.  Bayesian neural networks for bivariate binary data: an application to prostate cancer study , 2005, Statistics in medicine.

[26]  D. Pauler,et al.  Predicting time to prostate cancer recurrence based on joint models for non‐linear longitudinal biomarkers and event time outcomes , 2002, Statistics in medicine.

[27]  Jian-Ping Li,et al.  A Hybrid Intelligent System Framework for the Prediction of Heart Disease Using Machine Learning Algorithms , 2018, Mob. Inf. Syst..

[28]  Yingchun Zhang,et al.  A Fuzzy Reasoning Model for Cervical Intraepithelial Neoplasia Classification Using Temporal Grayscale Change and Textures of Cervical Images During Acetic Acid Tests , 2019, IEEE Access.

[29]  D. T. Arp,et al.  Prospective comparison of 68Ga-PSMA PET/CT, 18F-sodium fluoride PET/CT and diffusion weighted-MRI at for the detection of bone metastases in biochemically recurrent prostate cancer , 2018, European Journal of Nuclear Medicine and Molecular Imaging.

[30]  U. Rajendra Acharya,et al.  A novel machine learning approach for early detection of hepatocellular carcinoma patients , 2019, Cognitive Systems Research.

[31]  Cécile Proust-Lima,et al.  A joint model for multiple dynamic processes and clinical endpoints: Application to Alzheimer's disease , 2018, Statistics in medicine.

[32]  P. Vineis,et al.  Global cancer patterns: causes and prevention , 2014, The Lancet.

[33]  Yi-long Wu,et al.  Toward an Expert Level of Lung Cancer Detection and Classification Using a Deep Convolutional Neural Network. , 2019, The oncologist.

[34]  Zhigang Chen,et al.  Big Medical Data Decision-Making Intelligent System Exploiting Fuzzy Inference Logic for Prostate Cancer in Developing Countries , 2019, IEEE Access.

[35]  H. Heinzer,et al.  Initial Experience of (68)Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy. , 2016, European urology.

[36]  Hua Li,et al.  Benign and malignant classification of mammogram images based on deep learning , 2019, Biomed. Signal Process. Control..

[37]  F. Cavalli.  Cancer in the developing world: can we avoid the disaster? , 2006, Nature Clinical Practice Oncology.